Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-26 Sale | 2024-09-27 8:00 pm | COMPASS Pathways plc | CMPS | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner | 2,660,000 | $6.05 | $16,093,000 | 6,905,774 (Indirect) | View |
| 2024-05-16 Sale | 2024-05-20 5:30 pm | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 151,303 | $1.92 | $290,502 | 331,030 (Indirect Direct) | View |
| 2024-04-02 Sale | 2024-04-04 6:11 pm | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 27,410 | $1.85 | $50,709 | 73,590 (Direct) | View |
| 2024-04-02 Sale | 2024-04-04 6:11 pm | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 61,640 | $1.85 | $114,034 | 116,860 (Indirect Direct) | View |
| 2024-04-02 Sale | 2024-04-04 6:11 pm | ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer | 35,801 | $1.85 | $66,232 | 64,199 (Direct) | View |
| 2023-11-16 Purchase | 2023-11-20 09:17 am | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 20,000 | $1.156 | $23,120 | 132,333 (Indirect Direct) | View |
| 2023-09-13 Purchase | 2023-09-14 4:30 pm | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 40,000 | $1.4492 | $57,968 | 112,333 (Indirect Direct) | View |
| 2023-03-29 Purchase | 2023-03-30 5:55 pm | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 70,000 | $1.4794 | $103,558 | 72,333 (Indirect Direct) | View |
| 2023-03-29 Purchase | 2023-03-29 4:05 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 1,214,297 | $1.318 | $1,600,443 | 33,885,999 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-04 Disposition | 2024-10-04 4:32 pm | N/A 2025-08-20 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 624,000 | $0 | 624,000 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-04 4:32 pm | N/A 2030-08-20 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 624,000 | $0 | 624,000 (Direct) | View |
| 2024-10-04 Disposition | 2024-10-04 4:30 pm | N/A 2025-08-20 | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 441,568 | $0 | 441,568 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-04 4:30 pm | N/A 2030-08-20 | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 441,568 | $0 | 441,568 (Direct) | View |
| 2024-10-04 Disposition | 2024-10-04 4:30 pm | N/A 2025-08-20 | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 2,857,360 | $0 | 2,857,360 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-04 4:30 pm | N/A 2030-08-20 | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 2,857,360 | $0 | 2,857,360 (Direct) | View |
| 2024-10-04 Disposition | 2024-10-04 4:30 pm | N/A 2025-08-20 | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 4,978,800 | $0 | 4,978,800 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-04 4:30 pm | N/A 2030-08-20 | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 4,978,800 | $0 | 4,978,800 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 103,000 | $0 | 103,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Braunstein Scott Director | 206,000 | $0 | 206,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Fischer Laurent Director | 206,000 | $0 | 206,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2024-04-19 Other | 2024-05-03 4:05 pm | 2024-04-19 2026-02-01 | IntelGenx Technologies Corp. | IGXT | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner | 1,000,000 | $0 | 10,500,000 (Indirect) | View |
| 2024-04-15 Other | 2024-04-17 4:15 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 295,900 | $0 | 147,950 (Indirect) | View |
| 2024-03-13 Option Award | 2024-03-15 8:16 pm | N/A 2034-03-13 | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 550,000 | $0 | 751,000 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:16 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 100,000 | $0 | 751,000 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 8:16 pm | N/A 2034-03-13 | ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer | 550,000 | $0 | 750,000 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:16 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer | 100,000 | $0 | 750,000 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 8:16 pm | N/A 2034-03-13 | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 800,000 | $0 | 1,153,500 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:16 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 175,000 | $0 | 1,153,500 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-15 8:16 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 350,000 | $0 | 832,333 (Direct) | View |
| 2023-09-30 Other | 2024-03-12 9:36 pm | 2023-09-30 2026-08-31 | IntelGenx Technologies Corp. | IGXT | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner | 13,507,401 | $0 | 41,030,251 (Indirect) | View |
| 2024-01-05 Option Award | 2024-01-09 5:00 pm | N/A 2034-01-05 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 642,000 | $0 | 642,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:24 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:19 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:17 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:16 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Camm Jason Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:16 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 64,000 | $0 | 64,000 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 4:15 pm | N/A 2033-05-23 | ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director | 64,000 | $0 | 64,000 (Direct) | View |
Ownership | 2023-05-19 5:36 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Accounting Officer | 0 | $0 | 1,414,188 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 8:27 pm | N/A 2033-03-14 | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 950,000 | $0 | 950,000 (Direct) | View |